<DOC>
	<DOCNO>NCT03010865</DOCNO>
	<brief_summary>The purpose grant evaluate efficacy sodium butyrate novel treatment cognitive deficit schizophrenia ( SZ ) . The aims evaluate effect improve symptom function SZ , relationship drug 's clinical effect epigenetic inflammation relate biochemical change .</brief_summary>
	<brief_title>Sodium Butyrate For Improving Cognitive Function In Schizophrenia</brief_title>
	<detailed_description>The persistent cognitive deficit appreciate across course SZ , prodromal chronic SZ , may important underlie dysfunction prevent functional , occupational , social recovery SZ compare symptom domain . Sodium butyrate short chain fatty acid bind zinc site histone deacetylases ( HDAC ) . The inhibition HDAC result histone hyperacetylation . This study aim evaluate effect improve symptom function SZ , relationship drug 's clinical effect epigenetic inflammation relate biochemical change . The propose study double blind study effect sodium butyrate cognitive function symptom chronic SZ patient show continued cognitive deficits.The primary specific aim proposal test MATRICS ( MCCB ) battery , delay recall performance , performance real world functional task assess USCD Performance- Based Skills Assessment Battery ( UPSA ) . In addition , also investigate whether sodium butyrate may improve aspect cognition . We also explore whether improvement cognition relate change HDAC activity peripheral blood cell change inflammatory maker blood , ass whether improvement psychopathology measure PANSS scale .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Butyric Acid</mesh_term>
	<criteria>1 . Subjects cognitive deficit indicate score &lt; 85 RBANS , 2. meet criterion DSM5 diagnosis chronic SZ , schizoaffective disorder ( SA ) , 3 . Subjects stably treat antipsychotic medication acute exacerbation illness symptom . 1 . History mental retardation pervasive developmental disorder , 2 . Subjects current serious neurological/CNS disorder ( seizure disorder , stroke multiple sclerosis ) brain trauma , 3 . Current treatment valproic acid , butyrate drug , sulforaphane , drug chemical know high HDAC inhibitory activity , 4 . Pregnancy , 5 . Severe unstable medical condition , 6 . Current suicidal homicidal thought , 7 . Current alcohol substance abuse ( nicotine occasional marijuana ) last month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HDAC inhibitor</keyword>
	<keyword>Inflammation</keyword>
</DOC>